Skip to main navigation
Skip to search
Skip to main content
University College Cork Home
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
Search by expertise, name or affiliation
Early discontinuation of tamoxifen: A lesson for oncologists
Thomas I. Barron
,
Róisín M. Connolly
, Kathleen Bennett
, John Feely
, M. John Kennedy
St James's Hospital
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Early discontinuation of tamoxifen: A lesson for oncologists'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Oncologist
100%
Tamoxifen
100%
Breast Cancer
33%
Hormonal Therapy
22%
Cancer Mortality
11%
Antidepressant
11%
Anticarcinogen
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Breast Cancer
33%
Hormone Cancer Therapy
22%
Cancer Mortality
11%
Antidepressant
11%
Anticarcinogen
11%
Agricultural and Biological Sciences
Tamoxifen
100%
Malignant Neoplasm
33%
Mathematics
Cancer Patient
100%